Medicare Advantage contract
S1030 BlueRx (PDP)
Medicare Prescription Drug Plan · Parent: BlueCross BlueShield of Alabama
Latest enrollment
31,108
2025-01
Year-over-year
-2.5%
contract book
National MA share
+0.1%
rank #205 of 936
Overall stars (latest)
—
summary rating
Enrollment trend · 5 years
Star rating history
| Year | Overall | Part C | Part D | Δ |
|---|---|---|---|---|
| 2020 | — | — | 3.0 | — |
| 2021 | — | — | 3.5 | — |
| 2022 | — | — | 3.5 | — |
| 2023 | — | — | 3.0 | — |
| 2024 | — | — | 3.0 | — |
Premium
| Plan | Year | Monthly premium | Part D premium |
|---|---|---|---|
| S1030-001 | 2026 | $nan | $129.50 |
| S1030-006 | 2026 | $nan | $76.20 |
Premium analytics
Deeper cuts for investors and plan-strategy teams, delivered as a custom analysis.
Measure-level star movers
2023 → 2024- D04 Drug Plan Quality Improvement 3★ → 1★
- D12 Statin Use in Persons with Diabetes (SUPD) 2★ → 1★
- D01 Call Center Foreign Language Interpreter and TTY Availability 5★ → 4★
🔒 Want a custom analysis on this? — which measures moved, cut-point sensitivity, and
projected next-year exposure.
Talk to us →
County enrollment
0 counties| State | County | Enrollment |
|---|
Want a custom analysis on this?
Talk to us →County market share vs. competitors
service-area overlapHead-to-head share by county against named competitors, with expansion whitespace and defended turf.
Want a custom analysis on this?
Talk to us →